Prognostic significance of the presence of erythroblasts in blood after cardiothoracic surgery
Prognostic significance of the presence of erythroblasts in blood after cardiothoracic surgery
复制标题
DOI：
10.1515/cclm.2001.038
复制
发表时间：
2001-03-01
影响因子：
6.8
通讯作者：
Krieg, M
中科院分区：
文献类型：
--
作者：
Stachon, A;Böning, A;Krieg, M
在患有各种严重疾病的患者中，外周血中红细胞的检测与预后不良有关。然而，到目前为止，心胸手术后患者血液中的红细胞的预后意义还没有得到评估。在一项回顾研究中，我们分析了2074名患者的数据库，其中87名患者在术后期间在医院死亡。AH患者使用心肺机进行心胸手术。同时考虑了年龄、性别、体重指数、术前射血分数、吸烟、糖尿病、手术类型、急诊手术、肾功能不全、肺动脉高压和心内膜炎。外周血成红细胞者(57例)术后病死率为45.6%(26例)，差异有统计学意义(P<0.05)。
In patients suffering from a variety of severe diseases the detection of erythroblasts in peripheral blood is associated with poor prognosis. However, as yet the prognostic significance of erythroblasts in the blood of patients after cardiothoracic surgery has not been assessed. In a retrospective study we analyzed the database of 2074 patients, of whom 87 died in hospital during the postoperative period. AH patients underwent cardiothoracic surgery using a heart-lung machine. Together with erythroblasts in blood, age, sex, body mass index, preoperative ejection fraction, smoking, diabetes mellitus, type of operation, emergency surgery, renal deficiency, pulmonary hypertension, and endocarditis were considered. The postoperative mortality of patients with erythroblasts in peripheral blood (n=57) was 45.6% (n=26), being significantly higher (p